Sk Biopharmaceuticals Co., Ltd. is a leading biomedical company primarily engaged in the research, development, and commercialization of innovative pharmaceutical products. This company operates with ... Sk Biopharmaceuticals Co., Ltd. is a leading biomedical company primarily engaged in the research, development, and commercialization of innovative pharmaceutical products. This company operates with a strong focus on central nervous system (CNS) disorders, aiming to address unmet medical needs through its proprietary drug development programs. One of its notable achievements includes the development of therapies for epilepsy and Parkinson's disease, which highlights its commitment to advancing treatments in the CNS sector. Additionally, Sk Biopharmaceuticals is actively expanding its portfolio through strategic partnerships and collaborations in the biopharmaceutical industry. By leveraging advanced research facilities and a robust pipeline of clinical stage assets, the company plays a significant role in contributing to the pharmaceutical market's landscape. Its presence is crucial in enhancing the availability of targeted therapies, ultimately improving patient outcomes across global healthcare systems.Show lessShow more

Disclosures ESG Data Financial Data

GHG Emissions Climate Targets EU Taxonomy Energy Waste Management

Data not available

Energy Management data not yet covered for SK Biopharmaceuticals

We have not yet reviewed SK Biopharmaceuticals's disclosures for Energy Management data.

If this data is relevant to your work, you can submit a data coverage request and our team will investigate the company's disclosures and capture the data if available.

Would you like us to review SK Biopharmaceuticals's data?

Start your 30-day free trial to request a data review for SK Biopharmaceuticals.

Start Free Trial

Legal Center Contact Us